DUBLIN, Ohio (AP) _ Navidea Biopharmaceuticals Inc. (NAVB) on Thursday reported a loss of $3.1 million in its third quarter.
On a per-share basis, the Dublin, Ohio-based company said it had a loss of 17 cents.
The biopharmaceutical posted revenue of $236,800 in the period. Its adjusted revenue was $237,000.
In the final minutes of trading on Thursday, the company's shares hit 90 cents. A year ago, they were trading at $4.93.